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Background: Coughing during emergence from general anesthesia may be detrimental in children. We compared 
the effect of a small dose of propofol or ketamine administered at the end of sevoflurane anesthesia on the incidence 
or severity of coughing in children undergoing a minimal invasive operation.
Methods: One hundred and eighteen children aged between 3 and 15 years, American Society of Anesthesiologists 
(ASA) status I, were enrolled in this randomized double blind study. Anesthesia was induced with propofol or 
ketamine and maintained with sevoflurane in N2O/O2. Each group received propofol 0.25 mg/kg or ketamine 0.25 
mg/kg and the control group received saline 0.1 ml/kg. The decision to perform tracheal extubation was based on 
specified criteria, including the resumption of spontaneous respiration. During emergence from anesthesia and 
extubation, coughing was observed and graded at predefined times.
Results: The incidence of emergence without coughing was higher in the propofol group than in the ketamine and 
control group (19%, 11% and 6%, respectively), whereas the incidence of severe coughing was higher in the control 
group than in propofol and ketamine group (17.14%, 10.0% and 6.98%, respectively).
Conclusions: The addition of propofol 0.25 mg/kg decreased the incidence of coughing after sevoflurane general 
anesthesia in children undergoing non-painful procedures. (Korean J Anesthesiol 2011; 60: 25-29)
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Introduction
    During emergence from general anesthesia, airway irritation 
at extubation causes coughing which often causes serious side-
effects, but coughing is accepted as a biological response that 
protects the airway from aspiration [1]. However, coughing not 
only causes heavy discomfort to the patient, but also causes 
hypertension and palpitation, elevates intracranial pressure, 
intraocular pressure, and abdominal pressure, and causes 
coronary ischemia and arrhythmia [2-5]. Airway irritation 
causing coughing in pediatric patients can also cause life-
threatening laryngospasm [6].
    There has been considerable research conducted on methods 
and drugs to prevent coughing during emergence such as 
extubation at a great anesthetic depth [7], the use of LMA [8], the 
administration of IV lidocaine [9], short-acting opioids [10,11], 
dexmedetomidine [12], and lidocaine by local administration 
[13] or by cuff [14]. These methods all come with advantages 
and disadvantages.
    Propofol at the anesthetic dose is known to strongly suppress 
airway responses [15,16]. At a lower concentration than the 
anesthetic dose, propofol is known to prevent laryngospasm 
during extubation in pediatric patients [17]. Ketamine, due to 
its effects on sympathetic treacheal dilatory effect, is considered 
an attractive intravenous anesthetic for asthmatic patients 
needing anesthesia and intubation for recovery from asthmatic 
symptoms [18]. 
    However, the effects of propofol and ketamine in preventing 
coughing during emergence have not been analyzed in 
pediatric patients until now. Therefore, we have performed this 
study in order to analyze the effects of a low dose of propofol or 
ketamine on laryngospasm and the cough response during the 
emergence from anesthesia.
Materials and Methods
    After receiving approval for the present study from the ethics 
committee of the hospital, the anesthesia and study methods 
were explained to the guardian of patients. The study proceeded 
upon receiving the written consent from the guardian of patients 
participating in the study. 118 ASA I patients of 3-15 years 
who were scheduled for noninvasive surgery under general 
anesthesia such as strabismus correction and indirect hernia 
repair were chosen for the study. Patients were excluded from 
the study if they had a past history of sleep apnea syndrome, 
deve  lop  mental disorder, airway or facial abnormalities, bronchial 
asthma, an allergic disorder, or if they had an upper respiratory 
infection symptom during the surgery (Table 1).
    All patients were NPO. As pre-anesthetic medication, 
glycopyrrolate 0.004 mg/kg was IM administrated 30 min before 
surgery. On the OR table, noninvasive monitoring of blood 
pressure, EKG, and pulse oxymetry were initiated. Anesthetic 
induction was done by IV administration of ketamine 1.5 mg/kg 
or propofol 2 mg/kg. At the loss of consciousness, rocuronium 
0.8 mg/kg was IV administered and intubation was performed. 
Anesthetic maintenance was performed by O2 and N2O each 
at 1.5 L/min, sevoflurane was administered at 2.0-2.5 vol%, 
and controlled respiration was performed with capnogram 
maintained at 30-35 mmHg.
    At the end of the surgery, the level of muscle relaxation was 
evaluated by the use of Train-of-four. If three or more twitches 
occurred, then the residual muscle relaxants, pyridostigmine 
0.2 mg/kg and glycopyrolate 0.01 mg/kg were IV administered. 
Afterwards, sevoflurane and N2O were turned off, and manual 
ventilation was performed by O2 at 4 L/min. A doctor blind to 
the anesthesia study placed the test patients randomly in the 
control group, the propofol group, and the ketamine group. 
Normal saline 0.1 ml/kg was IV administered in the control 
group, propofol 0.25 mg/kg in the propofol group, and ketamine 
0.25 mg/kg in the ketamine group. The anesthesiologist gave 
the patients the drugs prepared by the blinded doctor. The 
administration time of the drugs given on emergence were 
defined in the study by Batra et al. [17], which were either when 
the pediatric patient’s breathing pattern returned to normal, 
or when the patient opened their eyes or made concentrated 
movement such as trying to remove the endotracheal tube with 
his hands. One min after administering the drugs respective 
of the groups, the endotracheal secretion was aspired and 
removed, and following that, the patient was extubated.
    After extubation, when the return of normal breathing was 
confirmed, the patient was moved to the PACU. During this 
process, laryngospasm and cough responses within 2 minutes 
after extubation were recorded based on the on the study by 
Batra et al. [17]. When there were no symptoms, grade 0 was 
given. When a stridor was heard, grade 1 was given. When there 
was spontaneous respiratory effort but suspicion of complete 
stenosis in the trachea, grade 2 was given. When SpO2 was 
85% or below or when cyanosis was observed due to airway 
obstruction, grade 3 was given. The severity of coughing was 
Table 1. Patient Characteristics for the Different Groups
Propofol 
group
(n = 40)
Ketamine 
group
(n = 43)
Control 
group
(n = 35)
Age (yr)
Weight (kg)
Height (cm)
Gender (male/female)
Operation time (min)
6.8 ± 3.2
26.1 ± 14.9
122.2 ± 19.2
26/17
43.6 ± 22.2
8.6 ±2.2
33.6 ± 8.0
131.4 ± 14.6
23/17
     45 ± 20.1
8.1 ± 2.7
31.5 ± 10.6
130.9 ± 14.1
22/13
56.1 ± 20.9
Values are mean ± SD or number of patients.27 www.ekja.org
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determined by using the graded categorizations of Minogue et 
al. [13]. After extubation, no incidence of coughing was given 
grade 0, only one cough was given grade 1, two coughs to slight 
coughing was grade 2, and severe or repetitive coughing was 
given grade 3.
    With laryngospasm after extubation, positive pressure 
ventilation was performed by a face mask with 100% oxygen. If 
no recovery occurred, the laryngospasm continued, and SpO2 
dropped to 85% or below, a small dose of propofol (0.8 mg/
kg) was administered and positive pressure ventilation was 
maintained. If laryngospasm persisted, succinylcholine was 
administered, the patient was intubated, and then ventilated 
with 100% oxygen in the study.
    After assessing the cough responses and laryngospasm on 
emergence, the recovery status was recorded twice by a nurse 
blinded to the experiment, once upon the patient arriving into 
PACU, and 30 min later in the PACU based on the recovery score 
(Table 2).
    The scores were shown as mean ± SD or in percentages. SPSS 
software version 17.0 ( SPSS Inc., Chicago, IL, USA) was used. 
Score ratios were assessed by Pearson’s χ
2 test, and continuous 
variables were assessed by a two-tailed unpaired t-test. The P 
value was considered statistically significant if below 0.05.
Results
    There were no significant differences observed in the child 
patient’s age, weight, height, gender, and operation time (Table 1). 
Fig. 1 shows the severity of coughing, the absolute scores, and 
relative rates of each group. The control group had 17.14% cases 
of severe coughing given grade 3. This was considerably higher 
than the propofol group which had 10% and the ketamine group 
which had 6.98%. For no coughing (grade 0), the control group 
had 6%, whereas the ketamine group had 11% and the propofol 
group had 19%. Pearson’s χ
2 test on the propofol group and the 
control group showed a significant difference of P = 0.047, but 
the test on the ketamine group and the control group showed 
no significant difference of P > 0.05. 
    Also on laryngospasm, all patients in the propofol group and 
the ketamine group received grade 0. There were 3 cases of 
grade 1 only in the control group, but there was no statistical 
significance (P > 0.05). There were no significant differences in 
the recovery scores in the PACU (Table 3) (P > 0.05). There were 
no significant differences (P > 0.05) in the types of surgeries 
(Table 4).
Discussion
    Although in the past there has been research on the 
suppression of laryngospasm in children by the administration 
of small doses of propofol [19], there were no reports on 
Fig. 1. Occurrence of cough (Grades 0-3) and the percentage of 
coughing events recorded in each group (propofol, ketamine, 
control). The table provides the absolute recorded numbers and 
proportions [n=number of Grades 0, 1, 2, or 3 coughing events 
recorded, irrespective of the time point of interest (%, proportion 
of the total number of coughing events in the group)]. Grade 0, no 
cough; Grade 1, mild cough; Grade 2, moderate cough; Grade 3, 
severe cough. Propofol vs control (P = 0.047). Ketamine vs control (P 
> 0.05) by Pearson χ
2 tests.
Table 2. Recovery Scores
0 1 2
Activity
Respiration
Circulation
Consciousness
Color
None
None
±50% of preop.
No response
Cyanosis
Depression
Depression
± 20% of preop.
Not accurate
Mild change
Normal
Normal
±1 0% of preop.
Accurate
Normal
Preop.: preoperative values.
Table 3. Result of Recovery Score
Group At arrival 30 min
Propofol
Ketamine
Control
8.90 ± 0.71
8.84 ± 0.79
8.77 ± 0.77
9.45 ± 0.71
9.72 ± 0.50
9.43 ± 0.74
Values are mean ± SD or number of patients. P value is greater than 
0.05.28 www.ekja.org
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cough responses. Despite ketamine being used as an efficient 
tracheal dilator, there has been no research on the effect of its 
concentration dose below anesthetic dose on emergence. We 
learned from the presented research results that a low dose of 
propofol after sevoflurane/N2O anesthesia reduces coughing on 
emergence in children.
    Reports that used less propofol than the anesthetic dose 
generally used 0.8 mg/kg [19] or 0.5 mg/kg for the prevention 
of laryngospasm [17]. Ketamine 0.75 mg/kg was used in 
asthmatic patients to set back laryngospasm [20]. However, 
there have been no studies focused on reducing coughing 
on emergence from anesthesia. Also there have been no 
quantitative comparative studies between propofol and 
ketamine. Therefore, in the presented study we used an equal 
amount of propofol and ketamine, less than the doses used in 
research on laryngospasm and bronchospasm. In conclusion, 
propofol of 0.25 mg/kg showed a statistically significant ability 
to suppress coughing. In the present study, to compare propofol 
and ketamine, the same doses were used to not eliminate the 
possibility of significant results from the use of higher doses of 
ketamine. However, it must be considered that ketamine may 
raise endotracheal secretion, which has a negative effect on 
extubation. 
    There have been various reported frequencies of coughing 
on emergence from anesthesia. It is reported that they occur in 
96% patients after extubation [21]. Also, such cough responses 
occur from the chemically or mechanically sensitive ascending 
vagus nerve [22]. However, cough responses are also effected by 
other ascending nerves and organs, the thorax, the diaphragm, 
and nerves connected to the abdominal muscles [23]. It is not 
clear whether propofol can specifically suppress responses to 
airway irritation, yet there has been a report that it might be due 
to the diminishing effect of propofol on laryngeal responses [15]. 
Also, propofol is considered to effectively suppress N-methyl-D-
aspartate (NMDA) receptors and block the ascending pathway 
from the trachea [24]. Ketamine is known for its mechanism 
of suppressing NMDA receptors which effectively suppresses 
coughing [25]. In addition, ketamine relaxes the bronchiole 
muscle, suppresses the bronchus from constricting due to 
histamines, and reduces the possibility of tracheal spasms [26]. 
Such effects result not only from the build-up of catecholamines 
but also from the direct effect on the bronchial muscles [26].
    The frequencies of laryngospasm on emergence from 
anesthesia in children are reported to be 0.9% at the lowest and 
21-26% at the highest in certain surgeries such as tonsilectomy 
[17,27-30]. In the present study, there were 8.6% laryngospasm-
related responses in the control group, but there were no cases 
observed in the propofol or ketamine groups. 
    In summary, even a small dose of propofol 0.25 mg/kg on 
emergence from anesthesia has a significant suppressant effect. 
However, additional studies are required on quantified doses 
of propofol on the effect of cough responses on the emergence 
from anesthesia. Also in the present study, ketamine was used 
in surgeries such as tonsillectomy which is known to raise the 
frequency of laryngospasm, but nevertheless showed lower 
results than the known frequencies. This is most likely due to the 
effects of propofol and ketamine used in anesthetic induction. 
This assumption requires further comparative research with 
greater sample sizes.
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